- Delivering Pan India
Meroplan S® (Meropenem + Sulbactam) Meropenem 1000 mg + Sulbactam 500 mg (1.5 g) injection by Abbott. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Meropenem 1000 mg + Sulbactam 500 mg (1.5 g) |
|---|---|
| Manufacturer | Abbott |
| Country | India |
| Pack size | Meropenem 1000 mg + Sulbactam 500 mg (1.5 g): 1 vial / carton |
| Storage | Store as per carton and leaflet; original sealed pack |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Meroplan S® (Meropenem + Sulbactam) Meropenem 1000 mg + Sulbactam 500 mg (1.5 g) Injection — Meropenem and Sulbactam for Injection: A Sourcing Guide for Hospitals and Pharmacies
Meroplan S® is a brand of meropenem 1000 mg and sulbactam 500 mg for injection, marketed by Abbott as a 1.5 g combipack. The US prescribing information for meropenem for injection describes the meropenem component as a carbapenem for complicated skin, intra-abdominal and meningitis infections; no US-approved label exists for the fixed meropenem-sulbactam combination. Its approved use in India is defined by the Meroplan S pack insert and the Indian regulator. The decision to prescribe meropenem + sulbactam, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Meroplan S® (meropenem + sulbactam) Meropenem 1000 mg + Sulbactam 500 mg (1.5 g) injection to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the anti-biotic medicines category. Supply is in bulk/wholesale quantities only.
Meroplan S is a 1.5 g combipack of meropenem 1000 mg with sulbactam 500 mg as a sterile powder for intravenous use, supplied as one vial, under medical supervision.
How it works, according to the label: The reference label describes meropenem as a carbapenem that inhibits bacterial cell wall synthesis. Sulbactam is a β-lactamase inhibitor; how the combination is described is set out in the Meroplan S pack insert.
The current US prescribing information for meropenem for injection, USP (generic reference label for the meropenem component) (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Meroplan S pack insert.
No trial specific to this fixed combination is cited on this page. For the meropenem component, the MERINO randomized trial compared piperacillin-tazobactam with meropenem in bloodstream infections and was published by Harris et al. in JAMA in 2018. Evidence is cited for information only and is not a recommendation for any patient.
| Strength | Dosage form | Pack size (as shown on the carton) |
|---|---|---|
| Meropenem 1000 mg + Sulbactam 500 mg (1.5 g) | Powder for solution for injection or infusion | 1 vial / carton |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
This page is written for hospital pharmacists, critical-care and infectious-disease department buyers, and pharmacies that source injectable antibiotics. The product is prescribed and supervised by a physician, as described in the product information.
The reference label lists hypersensitivity (including anaphylaxis), Clostridioides difficile-associated diarrhea, and, for carbapenems, seizures and other central nervous system reactions as warnings, with diarrhea, nausea, headache, rash and injection-site reactions among commonly reported reactions. This list is not complete; the full prescribing information governs.
All use should follow the approved prescribing information and the instructions of the treating physician.
Please follow the storage instructions printed on the Meroplan S carton and leaflet. The reference label for meropenem notes that reconstituted solutions should be freshly prepared and not frozen. Keep out of reach of children.
Meroplan S is marketed by Abbott. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Meroplan S through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Meroplan S available in India?
A.K. Pharma supplies Meroplan S (meropenem + sulbactam) Meropenem 1000 mg + Sulbactam 500 mg (1.5 g) injection to hospitals and pharmacies in India. Contact us for current availability.
What does Meroplan S contain?
Meropenem 1000 mg with sulbactam 500 mg (1.5 g) as a combipack for injection.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
How should Meroplan S be stored?
Follow the carton; the meropenem reference label advises freshly prepared solutions that are not frozen.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
